Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Jiroutkova 2014 Intensive Care Medicine Experimental"

From Bioblast
(Created page with "{{Publication |title=Jiroutkova K, Ziak J, Krajcova A, Fric M, Dzupa V, Duska F (2014) The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness. Inte...")
Β 
Line 1: Line 1:
{{Publication
{{Publication
|title=Jiroutkova K, Ziak J, Krajcova A, Fric M, Dzupa V, Duska F (2014) The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness. Intensive Care Medicine Experimental 2:29. Β 
|title=Jiroutkova K, Ziak J, Krajcova A, Fric M, Dzupa V, Duska F (2014) The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness. Intensive Care Medicine Experimental 2:29. Β 
|info=[[http://www.icm-experimental.com/content/2/S1/P29]]
|info=[[http://www.icm-experimental.com/content/2/S1/P29|http://www.icm-experimental.com/content/2/S1/P29]]
|authors=Jiroutkova K, Ziak J, Krajcova A, Fric M, Dzupa V, Duska F
|authors=Jiroutkova K, Ziak J, Krajcova A, Fric M, Dzupa V, Duska F
|year=2014
|year=2014
|journal=Intensive Care Medicine Experimental
|journal=Intensive Care Medicine Experimental
|abstract=Mitochondrial dysfunction (bioenergetic failure) is
|abstract=Mitochondrial dysfunction (bioenergetic failure) is known to contribute to the development of multiorganmfailure in acute sepsis. The defect is mainly at the level of respiratory complex I [1,2].
knownt to contribute to the development of multiorgan
To assess whether mitochondrial dysfunction in skeletal muscle perists until protracted critical illness and whether it contributes to the development of ICU-acquired weakness.
failure in acute sepsis. The defect is mainly at the level
Β 
of respiratory complex I [1,2].
Muscle biopsies were obtained from critically ill patients with severe ICUAW (defined as MRC score < 24 on two separate tests) and from otherwise healthy controls undergoing elective hip replacement. 50-100mg of the native sample was homogenized by a technique which perserves mitochondria in their cytosolic context [3]. Oxygen consumption was measured by high-resolution respirometry (Oxygraph-2Km Oroboros) under two occasions: 1. homogenate enriched with substrates was sequentially treated with an ATPase inhibitor (oligomycine), an uncoupler (FCCP) and KCN. This allowed us to measure oxidative phosphorylation, respiratory chain capacity, proton leak through inner mitochondrial membrane and non-mitochondrial O2 consumption. 2. skeletal muscle homogenate enriched with abundant ADP was treated with sequential addition of substrates and inhibitors of complexes I, II, III, and IV, respectively. Integrity of outer membrane was assessed by measuring the response to addition of cytochrome c. Oxygen consumption rate was normalized to citrate-synthase activity and total protein content.
Objectives
Β 
To assess whether mitochondrial dysfunction in skeletal
In skeletal muscle of patients with protracted critical illness and severe ICUAW we have found the activity of complex II and III to be >200% of activity of healthy controls. Function of complexes I and IV was identical as were global mitochondrial function/integrity indices. Upregulation of complex II may represent an adaptive phenomenon as skeletal muscle during critical illness is more reliant on fatty oxidation (which feeds electrons to respiratory chain via complex II), because of insulin resistance and impaired oxidative glucose disposal.
muscle perists until protracted critical illness and whether
Β 
it contributes to the development of ICU-acquired
In patients with severe ICUAW we have demonstrated increased activity of respiratory chain complexes downstream to complex I and intact global mitochondrial function. This may represent an adaptation to insulin
weakness.
Methods
Muscle biopsies were obtained from critically ill patients
with severe ICUAW (defined as MRC score < 24 on two
separate tests) and from otherwise healthy controls under-
going elective hip replacem
ent. 50-100mg of the native
sample was homogenized by a technique which perserves
mitochondria in their cytosolic context [3]. Oxygen con-
sumption was measured by high-resolution respirometry
(Oxygraph-2Km Oroboros) under two occasions: 1. homo-
genate enriched with substrates was sequentially treated
with an ATPase inhibitor (oligomycine), an uncoupler
(FCCP) and KCN. This allowed us to measure oxidative
phosphorylation, respiratory chain capacity, proton leak
through inner mitochondrial membrane and non-mito-
chondrial O2 consumption. 2. skeletal muscle homogenate
enriched with abundant ADP was treated with sequential
addition of substrates and inhibitors of complexes I, II, III,
and IV, respectively. Integrity of outer membrane was
assessed by measuring the response to addition of cyto-
chrome c. Oxygen consumption rate was normalized to
citrate-synthase activity and total protein content.
Results
In skeletal muscle of patients
with protracted critical ill-
ness and severe ICUAW we have found the activity of
complex II and III to be >200% of activity of healthy con-
trols. Function of complexes I and IV was identical as
were global mitochondrial function/integrity indices.
Upregulation of complex II may represent an adaptive
phenomenon as skeletal muscle during critical illness is
more reliant on fatty oxidation (which feeds electrons to
respiratory chain via complex II), because of insulin
resistance and impaired oxidative glucose disposal.
Conclusions
In patients with severe ICUAW we have demonstrated
increased activity of respiratory chain complexes down-
stream to complex I and intact global mitochondrial function. This may represent an adaptation to insulin
resistance.
resistance.
}}
}}
{{Labeling
{{Labeling

Revision as of 15:53, 5 November 2014

Publications in the MiPMap
Jiroutkova K, Ziak J, Krajcova A, Fric M, Dzupa V, Duska F (2014) The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness. Intensive Care Medicine Experimental 2:29.

Β» [[1]]

Jiroutkova K, Ziak J, Krajcova A, Fric M, Dzupa V, Duska F (2014) Intensive Care Medicine Experimental

Abstract: Mitochondrial dysfunction (bioenergetic failure) is known to contribute to the development of multiorganmfailure in acute sepsis. The defect is mainly at the level of respiratory complex I [1,2]. To assess whether mitochondrial dysfunction in skeletal muscle perists until protracted critical illness and whether it contributes to the development of ICU-acquired weakness.

Muscle biopsies were obtained from critically ill patients with severe ICUAW (defined as MRC score < 24 on two separate tests) and from otherwise healthy controls undergoing elective hip replacement. 50-100mg of the native sample was homogenized by a technique which perserves mitochondria in their cytosolic context [3]. Oxygen consumption was measured by high-resolution respirometry (Oxygraph-2Km Oroboros) under two occasions: 1. homogenate enriched with substrates was sequentially treated with an ATPase inhibitor (oligomycine), an uncoupler (FCCP) and KCN. This allowed us to measure oxidative phosphorylation, respiratory chain capacity, proton leak through inner mitochondrial membrane and non-mitochondrial O2 consumption. 2. skeletal muscle homogenate enriched with abundant ADP was treated with sequential addition of substrates and inhibitors of complexes I, II, III, and IV, respectively. Integrity of outer membrane was assessed by measuring the response to addition of cytochrome c. Oxygen consumption rate was normalized to citrate-synthase activity and total protein content.

In skeletal muscle of patients with protracted critical illness and severe ICUAW we have found the activity of complex II and III to be >200% of activity of healthy controls. Function of complexes I and IV was identical as were global mitochondrial function/integrity indices. Upregulation of complex II may represent an adaptive phenomenon as skeletal muscle during critical illness is more reliant on fatty oxidation (which feeds electrons to respiratory chain via complex II), because of insulin resistance and impaired oxidative glucose disposal.

In patients with severe ICUAW we have demonstrated increased activity of respiratory chain complexes downstream to complex I and intact global mitochondrial function. This may represent an adaptation to insulin resistance.


Labels: MiParea: Respiration 





HRR: Oxygraph-2k